-
EP3240574
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3240574
| EP3240574 - GLYCOPEPTIDES AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.11.2018 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 06.10.2017 | ||
| Former | The international publication has been made Status updated on 27.06.2017 | Most recent event Tooltip | 02.11.2018 | Application deemed to be withdrawn | published on 05.12.2018 [2018/49] | Applicant(s) | For all designated states Jawaharlal Nehru Centre For Advanced Scientific Research Jakkur, Bangalore 560 064 / IN | [2017/45] | Inventor(s) | 01 /
HALDAR, Jayanta Faculty Fellow New Chemistry Unit JNCASR Bangalore 560064 / IN | 02 /
YARLAGADDA, Venkateswarlu New Chemistry Unit JNCASR Bangalore 560064 / IN | [2017/45] | Representative(s) | MacLean, Martin Robert, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2017/45] | MacLean, Martin Robert, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 15843087.6 | 24.12.2015 | [2017/45] | WO2015IN50216 | Priority number, date | IN2014CHE6565 | 25.12.2014 Original published format: IN 6565CH2014 | [2017/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016103284 | Date: | 30.06.2016 | Language: | EN | [2016/26] | Type: | A1 Application with search report | No.: | EP3240574 | Date: | 08.11.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.06.2016 takes the place of the publication of the European patent application. | [2017/45] | Search report(s) | International search report - published on: | EP | 30.06.2016 | Classification | IPC: | A61K47/50, C07K9/00 | [2017/45] | CPC: |
C07K9/008 (EP,US);
A61P31/04 (EP);
A61K38/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/45] | Title | German: | GLYKOPEPTIDE UND VERWENDUNGEN DAVON | [2017/45] | English: | GLYCOPEPTIDES AND USES THEREOF | [2017/45] | French: | GLYCOPEPTIDES ET UTILISATIONS DE CEUX-CI | [2017/45] | Entry into regional phase | 26.06.2017 | National basic fee paid | 26.06.2017 | Designation fee(s) paid | 26.06.2017 | Examination fee paid | Examination procedure | 26.06.2017 | Examination requested [2017/45] | 26.06.2017 | Date on which the examining division has become responsible | 05.02.2018 | Amendment by applicant (claims and/or description) | 31.05.2018 | Application deemed to be withdrawn, date of legal effect [2018/49] | 09.07.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the invitation to file a copy of earlier search results or a statement of non-availability not received in time [2018/49] | Fees paid | Renewal fee | 29.12.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0039156 (ADVANCED MEDICINE INC [US], et al) [X] 1 * Abstract; compounds 142, 143, 154. *; | [Y]EP0667353 (LILLY CO ELI [US]) [Y] 1-11,13-20 * Abstract; compounds 1-244. *; | [Y]WO9630401 (LILLY CO ELI [US], et al) [Y] 1-11,13-20 * Abstract; compounds 245-288. *; | [XY] - VENKATESWARLU YARLAGADDA ET AL, "Tackling vancomycin-resistant bacteria with 'lipophilic-vancomycin-carbohydrate conjugates'", THE JOURNAL OF ANTIBIOTICS, (20141029), doi:10.1038/ja.2014.144, ISSN 0021-8820, XP055160013 [X] 1 * Abstract; Fig. 1. * [Y] 1-11,13-20 DOI: http://dx.doi.org/10.1038/ja.2014.144 | [X] - LEADBETTER M R ET AL, "Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)", THE JOURNAL OF ANTIBIOTICS, NATURE PUBLISHING GROUP, GB, vol. 57, no. 5, doi:10.7164/ANTIBIOTICS.57.326, ISSN 0021-8820, (20040501), pages 326 - 336, (20090127), XP002734111 [X] 1 * Abstract; compound 17. * DOI: http://dx.doi.org/10.7164/antibiotics.57.326 | [XP] - VENKATESWARLU YARLAGADDA ET AL, "Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, DE, (20151016), vol. 54, no. 46, doi:10.1002/anie.201507567, ISSN 1433-7851, pages 13644 - 13649, XP055267551 [XP] 1-20 * the whole document * DOI: http://dx.doi.org/10.1002/anie.201507567 | by applicant | WO2013072838 | US7632918 | - N. WOODFORD; D. M. LIVERMORE, "Infections caused by Gram-positive bacteria: A review of the global challenge", J. INFECT., (2009), vol. 59, pages S4 - S 16 | - D. KAHNE; C. LEIMKUHLER; W. LU; C. T. WALSH, "Glycopeptide and lipopeptide antibiotics", CHEM. REV., (2005), vol. 105, pages 425 - 448 | - V. YARLAGADDA; P. AKKAPEDDI; G. B. MANJUNATH; J. HALDAR, "Membrane active vancomycin analogues: A novel strategy to combat bacterial resistance", J. MED. CHEM., (2014), vol. 57, pages 4558 - 4568 |